Logo image of AXON

AXON ENTERPRISE INC (AXON) Stock Fundamental Analysis

NASDAQ:AXON - US05464C1018 - Common Stock

769.68 USD
+0.66 (+0.09%)
Last: 8/27/2025, 8:00:01 PM
776 USD
+6.32 (+0.82%)
After Hours: 8/27/2025, 8:00:01 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to AXON. AXON was compared to 68 industry peers in the Aerospace & Defense industry. AXON has an average financial health and profitability rating. AXON shows excellent growth, but is valued quite expensive already. These ratings would make AXON suitable for growth investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year AXON was profitable.
AXON had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AXON reported negative net income in multiple years.
Each year in the past 5 years AXON had a positive operating cash flow.
AXON Yearly Net Income VS EBIT VS OCF VS FCFAXON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

1.2 Ratios

AXON has a Return On Assets of 5.25%. This is in the better half of the industry: AXON outperforms 72.06% of its industry peers.
Looking at the Return On Equity, with a value of 11.94%, AXON belongs to the top of the industry, outperforming 80.88% of the companies in the same industry.
Industry RankSector Rank
ROA 5.25%
ROE 11.94%
ROIC N/A
ROA(3y)6.24%
ROA(5y)3.01%
ROE(3y)12.89%
ROE(5y)6.55%
ROIC(3y)N/A
ROIC(5y)N/A
AXON Yearly ROA, ROE, ROICAXON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

1.3 Margins

AXON has a better Profit Margin (13.64%) than 88.24% of its industry peers.
In the last couple of years the Profit Margin of AXON has grown nicely.
The Gross Margin of AXON (60.47%) is better than 92.65% of its industry peers.
In the last couple of years the Gross Margin of AXON has remained more or less at the same level.
Industry RankSector Rank
OM N/A
PM (TTM) 13.64%
GM 60.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y155.54%
GM growth 3Y-1.64%
GM growth 5Y0.59%
AXON Yearly Profit, Operating, Gross MarginsAXON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

6

2. Health

2.1 Basic Checks

AXON does not have a ROIC to compare to the WACC, probably because it is not profitable.
AXON has more shares outstanding than it did 1 year ago.
AXON has more shares outstanding than it did 5 years ago.
The debt/assets ratio for AXON has been reduced compared to a year ago.
AXON Yearly Shares OutstandingAXON Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
AXON Yearly Total Debt VS Total AssetsAXON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

AXON has an Altman-Z score of 11.48. This indicates that AXON is financially healthy and has little risk of bankruptcy at the moment.
AXON has a Altman-Z score of 11.48. This is amongst the best in the industry. AXON outperforms 88.24% of its industry peers.
AXON has a debt to FCF ratio of 11.38. This is a negative value and a sign of low solvency as AXON would need 11.38 years to pay back of all of its debts.
AXON has a Debt to FCF ratio of 11.38. This is in the better half of the industry: AXON outperforms 60.29% of its industry peers.
AXON has a Debt/Equity ratio of 0.63. This is a neutral value indicating AXON is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.63, AXON is not doing good in the industry: 61.76% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 11.38
Altman-Z 11.48
ROIC/WACCN/A
WACC9.93%
AXON Yearly LT Debt VS Equity VS FCFAXON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

AXON has a Current Ratio of 2.95. This indicates that AXON is financially healthy and has no problem in meeting its short term obligations.
AXON has a better Current ratio (2.95) than 64.71% of its industry peers.
A Quick Ratio of 2.71 indicates that AXON has no problem at all paying its short term obligations.
The Quick ratio of AXON (2.71) is better than 82.35% of its industry peers.
Industry RankSector Rank
Current Ratio 2.95
Quick Ratio 2.71
AXON Yearly Current Assets VS Current LiabilitesAXON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 57.24% over the past year.
Measured over the past years, AXON shows a very strong growth in Earnings Per Share. The EPS has been growing by 41.41% on average per year.
Looking at the last year, AXON shows a very strong growth in Revenue. The Revenue has grown by 32.37%.
AXON shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.44% yearly.
EPS 1Y (TTM)57.24%
EPS 3Y36.34%
EPS 5Y41.41%
EPS Q2Q%76.67%
Revenue 1Y (TTM)32.37%
Revenue growth 3Y34.11%
Revenue growth 5Y31.44%
Sales Q2Q%32.62%

3.2 Future

The Earnings Per Share is expected to grow by 19.51% on average over the next years. This is quite good.
Based on estimates for the next years, AXON will show a quite strong growth in Revenue. The Revenue will grow by 19.50% on average per year.
EPS Next Y16.3%
EPS Next 2Y17.2%
EPS Next 3Y19.51%
EPS Next 5YN/A
Revenue Next Year30.95%
Revenue Next 2Y27.61%
Revenue Next 3Y25.37%
Revenue Next 5Y19.5%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AXON Yearly Revenue VS EstimatesAXON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
AXON Yearly EPS VS EstimatesAXON Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8 10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 109.02, which means the current valuation is very expensive for AXON.
AXON's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.14. AXON is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 95.30, which means the current valuation is very expensive for AXON.
Based on the Price/Forward Earnings ratio, AXON is valued a bit more expensive than 63.24% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.80, AXON is valued quite expensively.
Industry RankSector Rank
PE 109.02
Fwd PE 95.3
AXON Price Earnings VS Forward Price EarningsAXON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AXON is valued a bit more expensive than 63.24% of the companies in the same industry.
AXON's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 342.34
EV/EBITDA 985.88
AXON Per share dataAXON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AXON does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as AXON's earnings are expected to grow with 19.51% in the coming years.
PEG (NY)6.69
PEG (5Y)2.63
EPS Next 2Y17.2%
EPS Next 3Y19.51%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AXON!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AXON ENTERPRISE INC

NASDAQ:AXON (8/27/2025, 8:00:01 PM)

After market: 776 +6.32 (+0.82%)

769.68

+0.66 (+0.09%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners81.96%
Inst Owner ChangeN/A
Ins Owners0.57%
Ins Owner Change5.42%
Market Cap60.42B
Analysts81.54
Price Target867.64 (12.73%)
Short Float %1.93%
Short Ratio2.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.34%
Min EPS beat(2)8.51%
Max EPS beat(2)42.17%
EPS beat(4)4
Avg EPS beat(4)28.65%
Min EPS beat(4)8.51%
Max EPS beat(4)45.27%
EPS beat(8)8
Avg EPS beat(8)26.23%
EPS beat(12)12
Avg EPS beat(12)33.52%
EPS beat(16)16
Avg EPS beat(16)60.63%
Revenue beat(2)2
Avg Revenue beat(2)2.58%
Min Revenue beat(2)1.38%
Max Revenue beat(2)3.78%
Revenue beat(4)3
Avg Revenue beat(4)1.6%
Min Revenue beat(4)-0.39%
Max Revenue beat(4)3.78%
Revenue beat(8)7
Avg Revenue beat(8)2.04%
Revenue beat(12)11
Avg Revenue beat(12)3.55%
Revenue beat(16)15
Avg Revenue beat(16)4.85%
PT rev (1m)13.38%
PT rev (3m)27.89%
EPS NQ rev (1m)-0.88%
EPS NQ rev (3m)-3.13%
EPS NY rev (1m)8.39%
EPS NY rev (3m)9.65%
Revenue NQ rev (1m)2.28%
Revenue NQ rev (3m)3.6%
Revenue NY rev (1m)2.18%
Revenue NY rev (3m)2.25%
Valuation
Industry RankSector Rank
PE 109.02
Fwd PE 95.3
P/S 25.26
P/FCF 342.34
P/OCF 219.25
P/B 22.11
P/tB 33.43
EV/EBITDA 985.88
EPS(TTM)7.06
EY0.92%
EPS(NY)8.08
Fwd EY1.05%
FCF(TTM)2.25
FCFY0.29%
OCF(TTM)3.51
OCFY0.46%
SpS30.47
BVpS34.81
TBVpS23.03
PEG (NY)6.69
PEG (5Y)2.63
Profitability
Industry RankSector Rank
ROA 5.25%
ROE 11.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 13.64%
GM 60.47%
FCFM 7.38%
ROA(3y)6.24%
ROA(5y)3.01%
ROE(3y)12.89%
ROE(5y)6.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.99%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y155.54%
GM growth 3Y-1.64%
GM growth 5Y0.59%
F-Score4
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 11.38
Debt/EBITDA 29.12
Cap/Depr 163.86%
Cap/Sales 4.14%
Interest Coverage N/A
Cash Conversion 464.18%
Profit Quality 54.09%
Current Ratio 2.95
Quick Ratio 2.71
Altman-Z 11.48
F-Score4
WACC9.93%
ROIC/WACCN/A
Cap/Depr(3y)192.5%
Cap/Depr(5y)286.11%
Cap/Sales(3y)4.12%
Cap/Sales(5y)5.78%
Profit Quality(3y)94.26%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.24%
EPS 3Y36.34%
EPS 5Y41.41%
EPS Q2Q%76.67%
EPS Next Y16.3%
EPS Next 2Y17.2%
EPS Next 3Y19.51%
EPS Next 5YN/A
Revenue 1Y (TTM)32.37%
Revenue growth 3Y34.11%
Revenue growth 5Y31.44%
Sales Q2Q%32.62%
Revenue Next Year30.95%
Revenue Next 2Y27.61%
Revenue Next 3Y25.37%
Revenue Next 5Y19.5%
EBIT growth 1Y-100.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year95.57%
EBIT Next 3Y48.75%
EBIT Next 5YN/A
FCF growth 1Y59.92%
FCF growth 3Y64.36%
FCF growth 5Y46.2%
OCF growth 1Y74.03%
OCF growth 3Y48.58%
OCF growth 5Y44.12%